Winstgevend schreef op 28 augustus 2018 15:31:
17 Sept. Start van de grote openbaring-show
21 Sept. Goedkeuring FDA Ruconest-Profylaxe
Q3 2018 Data release from Phase II Contrast-Induced-NephropatyCompletion date: Completed / Results Pending
Q3 2018 Decision FDA for Ruconest Prophylaxis (SBLA)Decision: September 21, 2018
Q3 2018 Start of Phase II Delayed Graft FunctionStarting date: September 2018
Q4 2018 Start clinical study Pre-Eclampsia26 Jul 2018 Pharming Group plans to submit an application in 3Q 2018
to conduct a phase I/II trial in Preeclampsia in Q4 2018
Date Unknown: Desicion EMA Ruconest Peadiatric aged 2-13 year oldfiled: October 2, 2017 - Decision: 2018
…. en nog steeds 1 Euro en 28 Cent...…………..